JP
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies | Frontiers in aging neuroscience |  | 2021 | 44 | 34 | ||
| Relationship between delirium and depression in old age | Swiss archives of neurology, psychiatry and psychotherapy | | 2021 | 177 | 67 | ||
| Replication study of plasma proteins relating to Alzheimer's pathology | Alzheimer's & dementia | | 2021 | 128 | 37 | ||
| A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort | Alzheimer's & dementia | | 2019 | 379 | 154 | ||
| Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay | Alzheimer's & Dementia | | 2019 | 259 | 185 | ||
| Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort | Alzheimer's & Dementia | | 2019 | 257 | 153 | ||
| Preoperative Depression and Plasma Cortisol Levels as Predictors of Delirium after Cardiac Surgery | Dementia and geriatric cognitive disorders |  | 2019 | 114 | 0 | ||
| The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research and Therapy |  | 2018 | 444 | 0 | ||
| Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease | Alzheimer's & Dementia | | 2018 | 372 | 3 | ||
| Do diurnal cortisol levels mediate the association between sleep disturbances and cognitive impairment? | Neurobiology of Aging | | 2018 | 405 | 0 | ||
| MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study | Alzheimer's Research and Therapy | | 2018 | 410 | 191 | ||
| Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia | Praxis (Bern 1994) | | 2018 | 442 | 0 | ||
| A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects | Analytica Chimica Acta | | 2018 | 414 | 1 | ||
| Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia | JAMA Psychiatry | | 2018 | 469 | 333 | ||
| The Effects of Hand Massage on Stress and Agitation Among People with Dementia in a Hospital Setting: A Pilot Study | Applied Psychophysiology and Biofeedback | | 2018 | 409 | 187 | ||
| Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization | Journal of Alzheimer's Disease | | 2017 | 717 | 0 | ||
| Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease | Alzheimer's & Dementia | | 2017 | 364 | 0 | ||
| Personality, Cortisol, and Cognition in Non-demented Elderly Subjects: Results from a Population-Based Study | Frontiers in Aging Neuroscience | | 2017 | 370 | 183 | ||
| Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia | Journal of Alzheimer's Disease | | 2017 | 417 | 0 | ||
| ICP-MS/MS-Based Ionomics: A Validated Methodology to Investigate the Biological Variability of the Human Ionome | Journal of Proteome Research | | 2017 | 383 | 1 | ||
| Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults | Journal of Alzheimer's Disease | | 2017 | 407 | 0 | ||
| Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology | Journal of Psychiatric Research | | 2017 | 728 | 1 | ||
| Life events, salivary cortisol, and cognitive performance in nondemented subjects: a population-based study | Neurobiology of Aging | | 2017 | 400 | 2 | ||
| One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond | Alzheimer's Research and Therapy | | 2017 | 475 | 186 | ||
| Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia | Experimental Gerontology | | 2017 | 368 | 0 | ||
| Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study | Neurology | | 2017 | 1,001 | 1 | ||
| Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults | Brain, Behavior and Immunity | | 2017 | 398 | 0 | ||
| Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance | Alzheimer's Research and Therapy | | 2017 | 365 | 161 | ||
| Response to a letter to the editor: sleep disturbance as a stressor event in elderly's life | Neurobiology of Aging | | 2017 | 370 | 0 | ||
| L'agitation chez les personnes atteintes de démence : examen de la portée des connaissances et mise en perspective du phénomène selon la théorie du confort et le concept de l'attachement | Recherche en soins infirmiers | | 2016 | 453 | 0 | ||
| Les biomarqueurs du liquide céphalorachidien dans la maladie d'Alzheimer en pratique clinique courante | Revue médicale suisse | | 2016 | 391 | 160 | ||
| Recommandations for prevention, diagnostic and therapy of delirium in the elderly | Praxis (Bern 1994) | 2016 | 370 | 0 | |||
| Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta | Journal of Neurochemistry | | 2016 | 396 | 0 | ||
| Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study | International Psychogeriatrics | | 2015 | 397 | 0 | ||
| Delirium in the elderly: Current problems with increasing geriatric age | Indian Journal of Medical Research | | 2015 | 369 | 253 | ||
| CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study | Alzheimer's and Dementia | | 2015 | 373 | 0 | ||
| Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type | Neurobiology of Aging | | 2015 | 369 | 0 | ||
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis | JAMA | | 2015 | 538 | 2 | ||
| Empfehlungen zur Diagnostik und Therapie der behavioralen und psychologischen Symptome der Demenz (BPSD) | Praxis (Bern 1994) | 2014 | 468 | 0 | |||
| Subjective cognitive decline in patients with mild cognitive impairment and healthy older adults: association with personality traits | Geriatrics and Gerontology International | | 2014 | 348 | 2 | ||
| SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease | Human Molecular Genetics | | 2014 | 338 | 1 | ||
| Predisposing and precipitating factors of delirium after cardiac surgery: a prospective observational cohort study | Annals of Surgery | | 2013 | 371 | 0 | ||
| The evolution of personality in patients with mild cognitive impairment | Dementia and Geriatric Cognitive Disorders | | 2013 | 378 | 0 | ||
| Delirium and cognitive decline: more than a coincidence | Current Opinion in Neurology | | 2013 | 308 | 0 | ||
| Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease | Biochemical Pharmacology | | 2013 | 379 | 0 | ||
| Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial | The Lancet Neurology | | 2013 | 302 | 0 |
